Faridoon Khan, MD | |
219 Cass Ave, Suite J, Woonsocket, RI 02895-4741 | |
(401) 766-7956 | |
(401) 765-7959 |
Full Name | Faridoon Khan |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 219 Cass Ave, Woonsocket, Rhode Island |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760446082 | NPI | - | NPPES |
3904 | Other | RI | MEDICAL LICENSE |
9000212 | Medicaid | RI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 3904 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Faridoon Khan, MD 219 Cass Ave, Suite J, Woonsocket, RI 02895-4741 Ph: (401) 766-7956 | Faridoon Khan, MD 219 Cass Ave, Suite J, Woonsocket, RI 02895-4741 Ph: (401) 766-7956 |
News Archive
UV radiation has been known for a long time to be a risk factor for the development of skin cancer. Simultaneous infection with human papillomaviruses (HPV) has also been suspected to promote skin cancer, particularly in organ transplant recipients.
The Pharmacy Care Alliance (PCA) today announced that AstraZeneca, Johnson & Johnson Pharmaceutical Companies, Inc., Eli Lilly and Company, Merck and Novartis will make many prescription drugs available to qualifying PCA Medicare discount cardholders free of charges from the manufacturer plus a nominal amount to cover dispensing, processing and other costs.
The Wall Street Journal reports that abortion-rights groups are mobilizing to keep a provision that would toughen abortion restrictions out of a Senate health care reform bill. "Activists hope to flood Washington to rally and lobby on Dec. 2, during the week that Senate floor debate begins." Ads are running to criticize the restrictions and a new coalition — the Coalition to Pass Health Care Reform and Stop Stupak — is being formed, The Journal reports.
Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) today announces the financial results and highlights for the second quarter ended June 30, 2009.
Folic acid supplementation does not increase or decrease the risk for cancer, suggests research published in The Lancet.
› Verified 2 days ago